Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway

J Ethnopharmacol. 2023 Jan 10:300:115719. doi: 10.1016/j.jep.2022.115719. Epub 2022 Sep 17.

Abstract

Ethnopharmacological relevance: Saffron, the dried stigma of Crocus sativus L., has a long history of use in the treatment of depression in traditional Chinese medicine and Islamic medicine. The unique aroma of saffron, primarily derived from its volatile oil, has been widely used by folk to mitigate anxiety and depression via sniffing because the aroma of saffron has a pleasant and invigorating effect.

Aim of the study: This study aimed to investigate the antidepressant effect and the underlying mechanism of saffron essential oil (SEO) in mice exposed to chronic unpredictable mild stress (CUMS).

Materials and methods: In this study, compounds of SEO were identified using gas chromatography-mass spectrometry analysis, while network pharmacology was used to predict potential active compounds, antidepressant targets, and related signaling pathways of SEO. The CUMS depression model was further used to explore the therapeutic effect and possible mechanism of SEO. During the modeling period, mice were regularly administered fluoxetine (3.6 mg/kg, i.g.) or diluted SEO (2%, 4%, and 6% SEO, inhalation). The antidepressant and neuroprotective effects of SEO were evaluated by behavior tests (the open field test, the sucrose preference test, the tail suspension test, and the forced swimming test), hematoxylin-eosin staining, and Nissl staining. The enzyme-linked immunosorbent assay kits were used to measure dopamine (DA), 5-serotonin (5-HT), brain-derived neurotrophic factor (BDNF), and γ-aminobutyric acid (GABA) levels in serum. The relative abundance of Raf1, MEK1, P-ERK1/2/ERK1/2, P-CREB1/CREB1, BDNF, and P-Trk B/Trk B in the hippocampus was determined using western blot (WB).

Results: According to the network pharmacology analysis, seven active SEO compounds mediated 113 targets related to depression treatment, most of which were enriched in the 5-HT synapse, calcium signaling pathway, and cAMP signaling pathway. In vivo experiments indicated that fluoxetine and SEO improved depression-like behaviors in depressed mice. The levels of 5-HT, DA, BDNF, and GABA in serum increased significantly. Histopathological examinations revealed that fluoxetine and SEO ameliorated neuronal damage in the hippocampus. WB analysis showed that the relative expressions of Raf1, MEK1, P-ERK1/2/ERK1/2, P-CREB1/CREB1, BDNF, and P-Trk B/Trk B were significantly higher in the fluoxetine and SEO groups than in the CUMS group.

Conclusion: Overall, these findings suggest that SEO significantly alleviates the depressive symptoms in CUMS exposed mice and partially restores hippocampal neuronal damage. Meanwhile, the best efficacy was observed in 4% SEO. Furthermore, the antidepressant mechanism of SEO is primarily dependent on the regulation of the MAPK-CREB1-BDNF signaling pathway.

Keywords: Antidepressant; BDNF; CREB1; MAPK cascade; Network pharmacology; Saffron essential oil.

MeSH terms

  • Animals
  • Antidepressive Agents / metabolism
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Behavior, Animal
  • Brain-Derived Neurotrophic Factor / metabolism
  • Crocus* / metabolism
  • Depression / drug therapy
  • Depression / etiology
  • Depression / metabolism
  • Disease Models, Animal
  • Dopamine / metabolism
  • Eosine Yellowish-(YS) / metabolism
  • Eosine Yellowish-(YS) / pharmacology
  • Fluoxetine / pharmacology
  • Hematoxylin / metabolism
  • Hematoxylin / pharmacology
  • Hippocampus
  • MAP Kinase Signaling System
  • Mice
  • Neuroprotective Agents* / pharmacology
  • Oils, Volatile* / metabolism
  • Oils, Volatile* / pharmacology
  • Oils, Volatile* / therapeutic use
  • Serotonin / metabolism
  • Signal Transduction
  • Stress, Physiological
  • Stress, Psychological / drug therapy
  • Sucrose / metabolism
  • Sucrose / pharmacology
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Neuroprotective Agents
  • Oils, Volatile
  • Fluoxetine
  • Serotonin
  • gamma-Aminobutyric Acid
  • Sucrose
  • Eosine Yellowish-(YS)
  • Dopamine
  • Hematoxylin